Cartherics is pleased to announce that PhD Candidate, Van To, will be presenting at the Association for Cancer Immunotherapy’s 20th CIMT Annual Meeting in Germany.
CIMT is Europe’s largest meeting focused on cancer immunotherapy research and development. Every year, the CIMT Annual Meeting connects the global cancer immunotherapy community in the heart of Europe. As the largest meeting focused on cancer immunotherapy research and development in Europe, CIMT invites international participants for high-level scientific exchange, collaboration, and education focused on cancer immunotherapy.
Van’s abstract, titled, Translating CAR-T cell therapy in the treatment of Cutaneous T cell Lymphoma, will be presented in the poster session on Wednesday 3rd May between 3pm – 5.30pm (CEST).
“CIMT is Europe’s largest meeting focused on cancer immunotherapy research and development. Being able to attend and present my work is a great honour, as it provides me with an opportunity to connect with experts from around the world and learn from their valuable insights,” said Ms To.